Wave Life Sciences Ltd (NASDAQ: WVE) stock closed at $4.97 on 12/19/23 after a major increase of 10.7%. Moreover, exceptionally high trading volume at 353% of normal accompanied the advance. The stock has been exceptionally strong relative to the market over the last nine months and has risen 19.5% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be below the cost of capital, WVE is expected to be a major Value Eraser.
Wave Life Sciences is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment